Search
for
Sort by
Research 391–420 of 1000+
- Culprits of Medication-Induced Telogen Effluvium, Part 1
- Efluvio telógeno
- An extract of <i>Leontopodium alpinum</i> inhibits catagen development ex vivo and increases hair density in vivo
- Methods in hair research: how to objectively distinguish between anagen and catagen in human hair follicle organ culture
- HNG, A Humanin Analogue, Promotes Hair Growth by Inhibiting Anagen-to-Catagen Transition
- Dietary Vitamin A Impacts Refractory Telogen
- Assessment of the effects of a hair lotion in women with acute telogen effluvium: a randomized controlled study
- Do Hair Bulb Melanocytes Undergo Apotosis During Hair Follicle Regression (Catagen)?
- Acute Telogen Effluvium: A Post-COVID-19 Sequela
- SARS-CoV-2 Infection—A Trigger Factor for Telogen Effluvium: Review of the Literature with a Case-Based Guidance for Clinical Evaluation
- Selective Elimination of NG2-Expressing Hair Follicle Stem Cells Exacerbates the Sensitization Phase of Contact Dermatitis in a Transgenic Rat Model
- Resting no more: re‐defining telogen, the maintenance stage of the hair growth cycle
- Recovery Effects of Oral Supplementation with Polar Lipid-Rich Wheat Extracts on Acute Telogen Effluvium: A Randomized Double-Blind Placebo-Controlled Study
- Thrombospondin-1 Plays a Critical Role in the Induction of Hair Follicle Involution and Vascular Regression During the Catagen Phase
- Expression of Cyclooxygenase Isozymes During Morphogenesis and Cycling of Pelage Hair Follicles in Mouse Skin: Precocious Onset of the First Catagen Phase and Alopecia upon Cyclooxygenase-2 Overexpression
- Postpartum Telogen Effluvium Unmasking Traction Alopecia
- The Role of the Hairless (hr) Gene in the. Regulation of Hair Follicle Catagen Transformation
- Involvement of the Edar Signaling in the Control of Hair Follicle Involution (Catagen)
- <i>Igf1r</i> signalling acts on the anagen‐to‐catagen transition in the hair cycle
- Effectiveness of Hair Care Products Containing Placental Growth Factor for the Treatment of Postpartum Telogen Effluvium
- A 2% Oleosome-FGF-2 Fusion Extract Scalp Serum Improves Photo-trichogramDerived Hair Density, Anagen/Telogen Ratio, Hair Shaft Thickness, and Scalp Barrier Parameters in Women with Shedding-Prone Hair: A Randomized, SingleBlind, Placebo-Controlled Pilot Study
- Retrospective Review of 2851 Female Patients With Telogen Effluvium: A Single‐Center Experience
- A hair loss pandemic: 19 cases of COVID-19 induced telogen effluvium
- Intermittent chronic telogen effluvium with an unusual dermoscopic finding following COVID ‐19
- COVID-19 infection is a major cause of acute telogen effluvium
- Clinical and histological challenge in the differential diagnosis of diffuse alopecia: female androgenetic alopecia, telogen effluvium and alopecia areata – part II
- Transcriptome Profiling and Differential Gene Expression in Canine Microdissected Anagen and Telogen Hair Follicles and Interfollicular Epidermis
- Analysis of Microscopic Examination of Pulled Out Hair in Telogen Effluvium Patients
- Efficacy Assessment of a Nutraceutical with a Marine Protein Complex in the Reduction of Female Telogen EffluviumEfficacy Assessment of a Nutraceutical with a Marine Protein Complex in the Reduction of Female Telogen Effluvium
- Paracrine TGF-β Signaling Counterbalances BMP-Mediated Repression in Hair Follicle Stem Cell Activation